Predictors of discontinuation in foslevodopa/foscarbidopa therapy for Parkinson's disease.

Saved in:
Bibliographic Details
Title: Predictors of discontinuation in foslevodopa/foscarbidopa therapy for Parkinson's disease.
Authors: Nishikawa N; Department of Neurology, Juntendo University Graduate School of Medicine, Tokyo, Japan. Electronic address: n.nishikawa.ts@juntendo.ac.jp., Hatano T; Department of Neurology, Juntendo University Graduate School of Medicine, Tokyo, Japan., Kamiyama D; Department of Neurology, Juntendo University Graduate School of Medicine, Tokyo, Japan., Kamo H; Department of Neurology, Juntendo University Graduate School of Medicine, Tokyo, Japan., Oji Y; Department of Neurology, Juntendo University Graduate School of Medicine, Tokyo, Japan., Abe C; Department of Neurology, Juntendo University Graduate School of Medicine, Tokyo, Japan., Shinada J; Department of Nursing, Juntendo University Hospital, Japan., Oyama G; Department of Neurology, Juntendo University Graduate School of Medicine, Tokyo, Japan., Hattori N; Department of Neurology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Source: Parkinsonism & related disorders [Parkinsonism Relat Disord] 2025 Jul; Vol. 136, pp. 107896. Date of Electronic Publication: 2025 May 26.
Publication Type: Letter
Journal Info: Publisher: Elsevier Science Country of Publication: England NLM ID: 9513583 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-5126 (Electronic) Linking ISSN: 13538020 NLM ISO Abbreviation: Parkinsonism Relat Disord Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1873-5126
DOI:10.1016/j.parkreldis.2025.107896